Discontinued — last reported Q3 '25
GE HealthCare Technologies Redeemable noncontrolling interests in subsidiaries increased by 4.3% to $218.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 3.3%, from $211.00M to $218.00M. Over 5 years (FY 2020 to FY 2025), Redeemable noncontrolling interests in subsidiaries shows relatively stable performance with a -1.3% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase indicates a higher potential future cash outflow obligation to minority shareholders, which may impact liquidity.
This represents the portion of equity in a subsidiary that is attributable to noncontrolling interests, which is subject...
Found in companies with complex organizational structures or joint venture arrangements; peers with significant M&A activity often carry these balances.
other_redeemable_noncontrolling_interest_equity_carrying_amount| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $220.00M | $229.00M | $220.00M | $198.00M | $230.00M | $201.00M | $209.00M | $161.00M | $165.00M | $177.00M | $177.00M | $177.00M | $188.00M | $211.00M | $220.00M | $204.00M | $209.00M | $218.00M |
| QoQ Change | — | +4.1% | -3.9% | -10.0% | +16.2% | -12.6% | +4.0% | -23.0% | +2.5% | +7.3% | +0.0% | +0.0% | +6.2% | +12.2% | +4.3% | -7.3% | +2.5% | +4.3% |
| YoY Change | — | — | — | — | +4.5% | -12.2% | -5.0% | -18.7% | -28.3% | -11.9% | -15.3% | +9.9% | +13.9% | +19.2% | +24.3% | +15.3% | +11.2% | +3.3% |